Growth Metrics

Opus Genetics (IRD) EPS (Basic) Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -13.31%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -100.00%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -79.34%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 61.11%
7 Evaxion A 62.56 Bn 62.54 Bn - -3,856.63%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -7.78%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1,207.14%
10 Opus Genetics 357.99 Mn 298.03 Mn - -212.50%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -212.50%
Dec 31, 2025 83.46%
Sep 30, 2025 13.79%
Jun 30, 2025 60.00%
Mar 31, 2025 17.24%
Dec 31, 2024 -504.76%
Sep 30, 2024 -211.54%
Jun 30, 2024 -25.00%
Mar 31, 2024 -3.57%
Dec 31, 2023 -112.21%
Sep 30, 2023 218.18%
Jun 30, 2023 4.00%
Mar 31, 2023 20.00%
Dec 31, 2022 1,055.56%
Sep 30, 2022 12.00%
Jun 30, 2022 51.92%
Mar 31, 2022 90.20%
Dec 31, 2021 95.10%
Sep 30, 2021 24.24%
Jun 30, 2021 -20.93%
Mar 31, 2021 -310.34%
Dec 31, 2020 -715.56%
Sep 30, 2020 32.65%
Jun 30, 2020 29.51%
Mar 31, 2020 -40.32%
Dec 31, 2019 -400.00%
Sep 30, 2019 75.74%
Jun 30, 2019 57.93%
Mar 31, 2019 21.52%
Dec 31, 2018 25.00%
Sep 30, 2018 -4,950.00%
Jun 30, 2018 -3,725.00%
Mar 31, 2018 13.19%
Dec 31, 2017 -500.00%
Sep 30, 2017 69.23%
Jun 30, 2017 150.00%
Mar 31, 2017 -355.00%
Dec 31, 2016 0.00%
Sep 30, 2016 -550.00%
Jun 30, 2016 -300.00%
Mar 31, 2016 -900.00%
Dec 31, 2015 -100.00%
Sep 30, 2015 -100.00%
Jun 30, 2015 -243.82%
Mar 31, 2015 77.78%
Dec 31, 2014 0.00%
Sep 30, 2014 50.00%
Jun 30, 2014 146.35%
Mar 31, 2014 -800.00%
Dec 31, 2013 -290.88%
Sep 30, 2013 33.33%
Jun 30, 2013 -200.00%
Mar 31, 2013 50.00%
Dec 31, 2012 -125.58%
Sep 30, 2012 -50.00%
Jun 30, 2012 83.33%
Mar 31, 2012 60.00%
Dec 31, 2011 133.33%
Sep 30, 2011 -802.93%
Jun 30, 2011 -20.00%